Surprisingly, a preclinical study showed that C/EBPα expression is also upregulated by IGF2; this finding is unexpected considering that the mitogen IGF2 should decrease the expression of tumour suppressor genes such as C/EBPα[135]. Here, IGF2 is linked to neoplasm.